Establishment and validation of a clinical model for predicting diabetic ketosis in patients with type 2 diabetes mellitus.

Yangang Wang, Mengmeng Qi, Xianfeng Shao, Ding Li, Yue Zhou, Lili Yang, Jingwei Chi, Kui Che, Min Xiao, Yanyun Zhao, Zili Kong, Wenshan Lv

Journal: Frontiers in endocrinology 2022;13():967929

PMID: 36339436

Abstract

BACKGROUND

Diabetic ketosis (DK) is one of the leading causes of hospitalization among patients with diabetes. Failure to recognize DK symptoms may lead to complications, such as diabetic ketoacidosis, severe neurological morbidity, and death.

PURPOSE

This study aimed to develop and validate a model to predict DK in patients with type 2 diabetes mellitus (T2DM) based on both clinical and biochemical characteristics.

METHODS

A cross-sectional study was conducted by evaluating the records of 3,126 patients with T2DM, with or without DK, at The Affiliated Hospital of Qingdao University from January 2015 to May 2022. The patients were divided randomly into the model development (70%) or validation (30%) cohorts. A risk prediction model was constructed using a stepwise logistic regression analysis to assess the risk of DK in the model development cohort. This model was then validated using a second cohort of patients.

RESULTS

The stepwise logistic regression analysis showed that the independent risk factors for DK in patients with T2DM were the 2-h postprandial C-peptide (2hCP) level, age, free fatty acids (FFA), and HbA1c. Based on these factors, we constructed a risk prediction model. The final risk prediction model was L= (0.472 - 0.202 - 0.078 + 0.005d - 4.299), where = HbA1c level, = 2hCP, = age, and = FFA. The area under the curve (AUC) was 0.917 (95% confidence interval [CI], 0.899-0.934; <0.001). The discriminatory ability of the model was equivalent in the validation cohort (AUC, 0.922; 95% CI, 0.898-0.946; <0.001).

CONCLUSION

This study identified independent risk factors for DK in patients with T2DM and constructed a prediction model based on these factors. The present findings provide an easy-to-use, easily interpretable, and accessible clinical tool for predicting DK in patients with T2DM.

Copyright © 2022 Qi, Shao, Li, Zhou, Yang, Chi, Che, Wang, Xiao, Zhao, Kong and Lv.

Address: Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China.; School of Public Health, Qingdao University, Qingdao, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.